Organ Tissue Engineering is a multidisciplinary field that combines principles of engineering, biology, and medicine to develop artificial organs or tissues for transplantation. The goal is to create functional substitutes capable of restoring or improving the normal physiological functions of damaged or diseased organs. This innovative approach addresses the shortage of donor organs for transplantation and aims to overcome issues like organ rejection. The process of organ tissue engineering involves utilizing scaffolds, cells, and signaling molecules. Scaffolds act as the structural framework, providing a three-dimensional environment for cell attachment and growth. Cells, often sourced from the patient or other compatible donors, are seeded onto the scaffolds. These cells can be stem cells, which possess the ability to differentiate into various cell types. Signaling molecules, such as growth factors, guide cell behavior and tissue development. Researchers explore various techniques, including 3D bioprinting, to precisely arrange cells and biomaterials, mimicking the architecture of native tissues. Decellularization, a process where cells are removed from donor organs, leaving behind the extracellular matrix, is another strategy used to create biological scaffolds for tissue engineering. Advances in organ tissue engineering have been seen in the development of functional tissues like skin, blood vessels, and cartilage. However, engineering complex organs such as the heart or liver presents significant challenges due to their intricate structure and function. Overcoming these challenges requires a deep understanding of the biology of the targeted organ and the development of sophisticated techniques to recreate its complexity. Ethical considerations, regulatory challenges, and the need for long-term functionality remain important aspects in the field of organ tissue engineering. Despite the ongoing research, the ultimate goal is to provide viable solutions for patients suffering from organ failure, offering alternatives to traditional transplantation and significantly impacting the future of medicine.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : The era of artificial intelligence (AI) and its use in regenerative medicine
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : The role of gingival fibroblasts in periodontal diseases and regeneration
Katarzyna Gawron, Medical University of Silesia in Katowice, Poland
Title : Channel fidelity limits in in-wound hydrogel printing for cartilage regeneration
Evgenia Papadimitriou, AVT.CVT, RWTH University, Germany
Title : Role of textile materials in tissue engineering and regenerative medicine
Gokarneshan Narayanan, SSM College of Engineering (Formerly), India